Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

VCYT – Veracyte, Inc.

Veracyte, Inc.
VCYT
$23.64
Name : Veracyte, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $1,851,357,056.00
EPSttm : 0.42
finviz dynamic chart for VCYT
Veracyte, Inc.
$23.64
0.55%
$0.13

Float Short %

7.92

Margin Of Safety %

12

Put/Call OI Ratio

0.39

EPS Next Q Diff

0.23

EPS Last/This Y

0.98

EPS This/Next Y

0.06

Price

23.64

Target Price

41.4

Analyst Recom

1.5

Performance Q

-20.43

Relative Volume

1.27

Beta

1.97

Ticker: VCYT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04VCYT27.21.170.34593
2025-07-07VCYT26.311.060.67603
2025-07-08VCYT26.581.050.00604
2025-07-09VCYT27.091.058.00605
2025-07-10VCYT27.511.06999.99609
2025-07-11VCYT27.081.060.00608
2025-07-14VCYT26.660.610.00828
2025-07-15VCYT25.230.600.07831
2025-07-16VCYT25.170.590.17844
2025-07-17VCYT24.220.580.28846
2025-07-18VCYT23.510.601.57877
2025-07-21VCYT23.030.460.05604
2025-07-22VCYT23.510.431.54628
2025-07-23VCYT24.230.470.00656
2025-07-24VCYT23.610.460.00661
2025-07-25VCYT25.260.450.04669
2025-07-28VCYT25.020.420.03716
2025-07-29VCYT24.50.370.90777
2025-07-30VCYT240.450.37862
2025-07-31VCYT23.530.430.00881
2025-08-01VCYT23.650.390.12956
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04VCYT27.51-0.370.21.30
2025-07-07VCYT26.33-0.365.61.30
2025-07-08VCYT26.58-0.371.51.30
2025-07-09VCYT27.08-0.372.61.30
2025-07-10VCYT27.52-0.372.31.30
2025-07-11VCYT27.08-0.370.51.30
2025-07-14VCYT26.65-0.368.71.30
2025-07-15VCYT25.24-0.364.51.30
2025-07-16VCYT25.17-0.370.21.30
2025-07-17VCYT24.22-0.366.21.30
2025-07-18VCYT23.51-0.367.11.30
2025-07-21VCYT23.01-0.368.01.30
2025-07-22VCYT23.50-0.372.81.30
2025-07-23VCYT24.21-0.374.01.30
2025-07-24VCYT23.59-0.367.51.30
2025-07-25VCYT25.25-0.378.61.30
2025-07-28VCYT25.06-0.369.61.30
2025-07-29VCYT24.47-1.268.01.30
2025-07-30VCYT23.97-1.268.11.30
2025-07-31VCYT23.51-1.268.31.30
2025-08-01VCYT23.64-1.271.11.30
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04VCYT-2.91-2.127.70
2025-07-07VCYT-2.11-2.127.70
2025-07-08VCYT-2.11-2.127.70
2025-07-09VCYT-2.11-2.127.70
2025-07-10VCYT-2.11-2.127.70
2025-07-11VCYT-2.11-2.127.99
2025-07-14VCYT-2.11-2.027.99
2025-07-15VCYT-2.11-2.027.99
2025-07-16VCYT-2.11-2.027.99
2025-07-17VCYT-2.11-2.027.99
2025-07-18VCYT-2.11-2.027.99
2025-07-21VCYT-2.11-2.207.99
2025-07-22VCYT-2.11-2.207.99
2025-07-23VCYT-2.11-2.207.99
2025-07-24VCYT-2.11-2.207.99
2025-07-25VCYT-2.11-2.207.92
2025-07-28VCYT-2.11-2.407.92
2025-07-29VCYT-2.15-2.407.92
2025-07-30VCYT-2.15-2.407.92
2025-07-31VCYT-2.15-2.407.92
2025-08-01VCYT-2.15-2.407.92
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.09

Avg. EPS Est. Current Quarter

0.3

Avg. EPS Est. Next Quarter

0.32

Insider Transactions

-2.15

Institutional Transactions

-2.4

Beta

1.97

Average Sales Estimate Current Quarter

120

Average Sales Estimate Next Quarter

124

Fair Value

26.58

Quality Score

58

Growth Score

59

Sentiment Score

7

Actual DrawDown %

72.5

Max Drawdown 5-Year %

-81.2

Target Price

41.4

P/E

56.35

Forward P/E

19.51

PEG

0.76

P/S

4

P/B

1.55

P/Free Cash Flow

23.6

EPS

0.42

Average EPS Est. Cur. Y​

1.3

EPS Next Y. (Est.)

1.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.13

Relative Volume

1.27

Return on Equity vs Sector %

-21

Return on Equity vs Industry %

-7.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

71.1
Veracyte, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 824
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
stock quote shares VCYT – Veracyte, Inc. Stock Price stock today
news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte, Inc. yahoo finance google finance
stock history VCYT – Veracyte, Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading